Ainos (AIMD) Competitors $0.48 -0.04 (-8.43%) As of 05/21/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock AIMD vs. COEP, LVTX, NLTX, BLUE, FBLG, DYAI, KZR, MRNS, FGEN, and ALZNShould you be buying Ainos stock or one of its competitors? The main competitors of Ainos include Coeptis Therapeutics (COEP), LAVA Therapeutics (LVTX), Neoleukin Therapeutics (NLTX), bluebird bio (BLUE), FibroBiologics (FBLG), Dyadic International (DYAI), Kezar Life Sciences (KZR), Marinus Pharmaceuticals (MRNS), FibroGen (FGEN), and Alzamend Neuro (ALZN). These companies are all part of the "pharmaceutical products" industry. Ainos vs. Coeptis Therapeutics LAVA Therapeutics Neoleukin Therapeutics bluebird bio FibroBiologics Dyadic International Kezar Life Sciences Marinus Pharmaceuticals FibroGen Alzamend Neuro Coeptis Therapeutics (NASDAQ:COEP) and Ainos (NASDAQ:AIMD) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, community ranking, institutional ownership, media sentiment, analyst recommendations, valuation and risk. Do analysts rate COEP or AIMD? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Coeptis Therapeutics 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Ainos 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is COEP or AIMD more profitable? Ainos' return on equity of -75.16% beat Coeptis Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Coeptis TherapeuticsN/A -1,094.50% -219.97% Ainos N/A -75.16%-50.22% Does the MarketBeat Community believe in COEP or AIMD? Coeptis Therapeutics received 5 more outperform votes than Ainos when rated by MarketBeat users. CompanyUnderperformOutperformCoeptis TherapeuticsOutperform Votes583.33% Underperform Votes116.67%AinosN/AN/A Which has preferable valuation and earnings, COEP or AIMD? Ainos has lower revenue, but higher earnings than Coeptis Therapeutics. Coeptis Therapeutics is trading at a lower price-to-earnings ratio than Ainos, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCoeptis Therapeutics$62.87K548.28-$21.27M-$5.80-1.69Ainos$20.73K360.64-$13.77M-$1.29-0.38 Which has more risk and volatility, COEP or AIMD? Coeptis Therapeutics has a beta of -0.66, meaning that its share price is 166% less volatile than the S&P 500. Comparatively, Ainos has a beta of 2.14, meaning that its share price is 114% more volatile than the S&P 500. Does the media refer more to COEP or AIMD? In the previous week, Ainos had 1 more articles in the media than Coeptis Therapeutics. MarketBeat recorded 1 mentions for Ainos and 0 mentions for Coeptis Therapeutics. Coeptis Therapeutics' average media sentiment score of 1.38 beat Ainos' score of 0.00 indicating that Coeptis Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Coeptis Therapeutics Positive Ainos Neutral Do insiders & institutionals have more ownership in COEP or AIMD? 13.9% of Coeptis Therapeutics shares are owned by institutional investors. 24.3% of Coeptis Therapeutics shares are owned by insiders. Comparatively, 10.4% of Ainos shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryCoeptis Therapeutics and Ainos tied by winning 7 of the 14 factors compared between the two stocks. Get Ainos News Delivered to You Automatically Sign up to receive the latest news and ratings for AIMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIMD vs. The Competition Export to ExcelMetricAinosPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.48M$6.48B$5.35B$8.38BDividend YieldN/A2.66%5.22%4.10%P/E Ratio-0.388.9226.8419.71Price / Sales360.64250.95391.39116.98Price / CashN/A65.8538.2534.62Price / Book0.096.466.794.50Net Income-$13.77M$143.98M$3.23B$248.18M7 Day Performance-8.43%3.04%4.07%1.14%1 Month Performance-10.13%7.44%12.52%15.20%1 Year Performance-51.56%-2.46%16.83%6.56% Ainos Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIMDAinos0.4752 of 5 stars$0.48-8.4%N/A-51.6%$7.48M$20,729.00-0.3840Gap DownCOEPCoeptis Therapeutics0.7074 of 5 stars$9.85-0.5%N/A+45.5%$33.15MN/A-1.702Positive NewsLVTXLAVA Therapeutics2.2168 of 5 stars$1.25-2.3%$3.17+153.3%-50.2%$32.88M$11.98M-1.2160Analyst RevisionNLTXNeoleukin TherapeuticsN/A$17.70+20.2%N/A-45.5%$32.80MN/A-5.6990Gap UpHigh Trading VolumeBLUEbluebird bio2.7073 of 5 stars$3.31+0.6%$44.60+1,247.4%-75.1%$32.41M$83.81M-0.09520FBLGFibroBiologics1.5636 of 5 stars$0.84-3.4%$13.00+1,447.6%-91.7%$32.14MN/A-2.4710DYAIDyadic International2.2771 of 5 stars$1.06-3.6%$6.00+466.0%-38.3%$31.90M$3.50M-4.617KZRKezar Life Sciences4.1523 of 5 stars$4.20-0.7%$39.50+840.5%-48.3%$30.69M$7M-0.3260MRNSMarinus Pharmaceuticals1.8693 of 5 stars$0.55-0.2%$4.79+771.6%-58.7%$30.32M$30.99M-0.22110News CoverageAnalyst ForecastFGENFibroGen4.3773 of 5 stars$0.30-2.0%$10.00+3,241.1%-72.1%$30.24M$29.62M-0.24570ALZNAlzamend Neuro2.9924 of 5 stars$4.18-18.8%$180.00+4,206.2%-93.9%$30.13MN/A0.004High Trading Volume Related Companies and Tools Related Companies COEP Competitors LVTX Competitors NLTX Competitors BLUE Competitors FBLG Competitors DYAI Competitors KZR Competitors MRNS Competitors FGEN Competitors ALZN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AIMD) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump + Musk = AI’s turning pointTrump may not code… but he knows how to pick winners. And according to insiders, his administration is prep...True Market Insiders | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ainos, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ainos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AIMD Stock Free AIMD Stock Alerts